Literature DB >> 22715214

Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update.

Bryce D Smith1, Cynthia Jorgensen, Jon E Zibbell, Geoff A Beckett.   

Abstract

Hepatitis C virus (HCV) infection is a complex public health problem, characterized by a high prevalence of chronic infection, an increasing burden of HCV-associated disease, low rates of testing and treatment, and the prospect of increasing incidence associated with the epidemic of injection drug use. Three-quarters of chronic HCV infections occur among persons born from 1945 through 1965. Prevention efforts are complicated by limited knowledge among health care professionals, persons at risk and in the public at large. At the Centers for Disease Control and Prevention, efforts to improve primary and secondary prevention effectiveness center on policy development, education and training initiatives, and applied research. This report provides a brief overview of some of these efforts, including the development of testing recommendations for the 1945-1965 birth cohort, research and evaluation studies in settings where persons who inject drugs receive services, and a national viral hepatitis education campaign that targets health care professionals, the public, and persons at risk.

Entities:  

Mesh:

Year:  2012        PMID: 22715214     DOI: 10.1093/cid/cis363

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

1.  Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010.

Authors:  Shahram Shahangian; Todd D Alspach; J Rex Astles; Ajay Yesupriya; William K Dettwyler
Journal:  Arch Pathol Lab Med       Date:  2013-06-05       Impact factor: 5.534

2.  The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care.

Authors:  Andrew D Schreiner; John Bian; Jingwen Zhang; Z Merle Haulsee; Justin Marsden; Valerie Durkalski-Mauldin; Patrick D Mauldin; William P Moran; Don C Rockey
Journal:  Am J Med       Date:  2019-07-29       Impact factor: 4.965

3.  Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Authors:  Eleanor E Friedman; Hazel D Dean; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-06       Impact factor: 2.792

4.  A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System.

Authors:  John T Nguyen; Josiah D Rich; Bradley W Brockmann; Fred Vohr; Anne Spaulding; Brian T Montague
Journal:  J Urban Health       Date:  2015-08       Impact factor: 3.671

5.  Age cohort differences in illicit drug use and hepatitis C among African American substance users.

Authors:  Nicole Ennis Whitehead; Lauren Hearn; Rebecca C Trenz; Larry E Burrell; William W Latimer
Journal:  J Addict Dis       Date:  2014

Review 6.  Evolving epidemiology of hepatitis C virus in the United States.

Authors:  R Monina Klevens; Dale J Hu; Ruth Jiles; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-07       Impact factor: 9.079

Review 7.  Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer.

Authors:  Jessica Brownell; Stephen J Polyak
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

8.  An Introduction to Virus Infections and Human Cancer.

Authors:  John T Schiller; Douglas R Lowy
Journal:  Recent Results Cancer Res       Date:  2021

9.  Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.

Authors:  Scott W Biggins; Kiran M Bambha; Norah A Terrault; John Inadomi; Stephen Shiboski; Jennifer L Dodge; Jane Gralla; Hugo R Rosen; John P Roberts
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

10.  National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States.

Authors:  James W Galbraith; John P Donnelly; Ricardo A Franco; Edgar T Overton; Joel B Rodgers; Henry E Wang
Journal:  Clin Infect Dis       Date:  2014-06-09       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.